APPLICATION
NDA021369
TYPE
NDA
ORIGINAL APPROVAL
2004-06-21
LATEST ACTION
2004-06-21
ROUTE
ORAL
DOSAGE FORM
SUSPENSION, EXTENDED RELEASE
MARKETING STATUS
Discontinued
Products
CODEPREXDiscontinued
CHLORPHENIRAMINE POLISTIREX EQ 4MG MALEATE/5ML, CODEINE POLISTIREX EQ 20MG BASE/5ML · SUSPENSION, EXTENDED RELEASE · ORAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.